Revolab health

Revolab Health is a remote health testing and tracking platform that leverages AI to turn lab-grade blood test result data into health insights. The Vilnius-based HealthTech startup has seen significant growth, generating over 100,000 € in revenues. It has also achieved noteworthy milestones, winning the 2020 EIT Digital Venture Program and securing a seed funding of 300,000 € in May 2021, with the investment led by Kilo Health. The company's at-home blood sample kit, offering lab-grade results within 24 hours and insights provided by general practitioners, has garnered attention. With a CE certification for in-vitro medical devices and FDA approval, Revolab has positioned itself for growth in 27 EU markets and the US. Moreover, the startup holds a medical license in Lithuania. The company's service is being reimbursed by Gjensidige and Compensa Group insurance partners, further solidifying its position in the market. Revolab's current focus is on strengthening its technology stack by enhancing its algorithmic features to provide users with trustworthy medical insightsML algorithms to complement blood test results and enhance diagnostics. Although currently operating mainly in Lithuania, the company is poised to expand into neighboring countries by the end of 2021.